On January 18, 2024, Eldon Mayer III notified Eiger BioPharmaceuticals, Inc. of his resignation as the Company?s Chief Commercial Officer, to be effective February 2, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.272 USD | +1.00% | -15.52% | -66.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.26% | 3.37M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.68% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Ldon Mayer Iii Notifies Eiger BioPharmaceuticals, Inc. of His Resignation as the Chief Commercial Officer, Effective February 2, 2024